Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6996)
All Articles published online
|
Publishing Process of This Article
|
Dec 14, 2019 (publication date) through Feb 14, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ou ZL, Luo Z, Lu YB. Long non-coding RNA HULC as a diagnostic and prognostic marker of pancreatic cancer. World J Gastroenterol 2019; 25(46): 6728-6742 [PMID: PMC6920662 DOI: 10.3748/wjg.v25.i46.6728] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i46/6728.htm |
| Number | Citing Articles |
| 1 |
Gouri Pandya, Anuradha Kirtonia, Gautam Sethi, Amit Kumar Pandey, Manoj Garg. The implication of long non-coding RNAs in the diagnosis, pathogenesis and drug resistance of pancreatic ductal adenocarcinoma and their possible therapeutic potential. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020; 1874(2): 188423 doi: 10.1016/j.bbcan.2020.188423
|
| 2 |
Yuan Qiao, Li-Jun Yan, Chao Yan. Sauchinone inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells through the Wnt/β-catenin pathway. Anti-Cancer Drugs 2020; 31(9): 918 doi: 10.1097/CAD.0000000000000956
|
| 3 |
Jialin Yang, Qin Ma, Mingming Zhang, Wanfu Zhang. RETRACTED ARTICLE: LncRNA CYTOR drives L-OHP resistance and facilitates the epithelial–mesenchymal transition of colon carcinoma cells via modulating miR-378a-5p/SERPINE1. Cell Cycle 2021; 20(14): 1415 doi: 10.1080/15384101.2021.1934626
|
| 4 |
Guangbing Xiong, Shutao Pan, Jikuan Jin, Xiaoxiang Wang, Ruizhi He, Feng Peng, Xu Li, Min Wang, Jianwei Zheng, Feng Zhu, Renyi Qin. Long Noncoding Competing Endogenous RNA Networks in Pancreatic Cancer. Frontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.765216
|
| 5 |
Abhijit Mandal, Sarbani Giri. Long Non-coding RNAs - Function, Mechanisms, and Applications [Working Title]. 2025; doi: 10.5772/intechopen.1008958
|
| 6 |
Valeria Tonini, Manuel Zanni. Pancreatic cancer in 2021: What you need to know to win. World Journal of Gastroenterology 2021; 27(35): 5851-5889 doi: 10.3748/wjg.v27.i35.5851
|
| 7 |
Moein Ala. Target c-Myc to treat pancreatic cancer. Cancer Biology & Therapy 2022; 23(1): 34 doi: 10.1080/15384047.2021.2017223
|
| 8 |
Chengyan Wei, Chunwei Zhang, Yuanzhi Zhou, Jingjing Wang, Yong Jin. Progress of Exosomal LncRNAs in Pancreatic Cancer. International Journal of Molecular Sciences 2024; 25(16): 8665 doi: 10.3390/ijms25168665
|
| 9 |
Robert S O'Neill, Alina Stoita. Biomarkers in the diagnosis of pancreatic cancer: Are we closer to finding the golden ticket?. World Journal of Gastroenterology 2021; 27(26): 4045-4087 doi: 10.3748/wjg.v27.i26.4045
|
| 10 |
Wenchong Song, Chengjian Shi. LncRNA RGMB-AS1 facilitates pancreatic cancer cell proliferation and migration but inhibits cell apoptosis via miR-574-3p/PIM3 axis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 321(5): G477 doi: 10.1152/ajpgi.00443.2020
|
| 11 |
Jiajia Li, Sicong Hou, Ziping Ye, Wujun Wang, Xiaolin Hu, Qinglei Hang. Long Non-Coding RNAs in Pancreatic Cancer: Biologic Functions, Mechanisms, and Clinical Significance. Cancers 2022; 14(9): 2115 doi: 10.3390/cancers14092115
|
| 12 |
Ruining Gong, Yueping Jiang. Non-coding RNAs in Pancreatic Ductal Adenocarcinoma. Frontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.00309
|
| 13 |
Jiang Huang, Yunfang Yang, Fulan Zhao, Zhuo Zhang, Jian Deng, Wei Lu, Xian Jiang. LncRNA SATB2-AS1 overexpression represses the development of hepatocellular carcinoma through regulating the miR-3678-3p/GRIM-19 axis. Cancer Cell International 2023; 23(1) doi: 10.1186/s12935-023-02901-1
|
| 14 |
Soudeh Ghafouri-Fard, Mohadeseh Fathi, Tianyue Zhai, Mohammad Taheri, Peixin Dong. LncRNAs: Novel Biomarkers for Pancreatic Cancer. Biomolecules 2021; 11(11): 1665 doi: 10.3390/biom11111665
|
| 15 |
Xiao-Yin Jiang, Qi-Cong Zhu, Xiao-Jian Zhang, Ting Duan, Jiao Feng, Xin-Bing Sui, Xue-Ni Sun, Yi-Ping Mou. Roles of lncRNAs in pancreatic ductal adenocarcinoma: Diagnosis, treatment, and the development of drug resistance. Hepatobiliary & Pancreatic Diseases International 2023; 22(2): 128 doi: 10.1016/j.hbpd.2022.12.002
|
| 16 |
Bo Liu, Tingting Fu, Ping He, Chengyou Du, Ke Xu. Construction of a five-gene prognostic model based on immune-related genes for the prediction of survival in pancreatic cancer. Bioscience Reports 2021; 41(7) doi: 10.1042/BSR20204301
|
| 17 |
Jiahui Tian, Chunyan Fu, Xuan Zeng, Xiaoxiao Fan, Yi Wu, Muhammad Babar Khawar. An Independent Prognostic Model Based on Ten Autophagy-Related Long Noncoding RNAs in Pancreatic Cancer Patients. Genetics Research 2022; 2022: 1 doi: 10.1155/2022/3895396
|
| 18 |
Safirul Islam, Chandrama Mukherjee. Molecular regulation of hypoxia through the lenses of noncoding RNAs and epitranscriptome. WIREs RNA 2023; 14(2) doi: 10.1002/wrna.1750
|
| 19 |
Milad Ashrafizadeh, Mohammad Hossein Gholami, Sepideh Mirzaei, Amirhossein Zabolian, Amirabbas Haddadi, Mahdi Vasheghani Farahani, Sharareh Hosseinzadeh Kashani, Kiavash Hushmandi, Masoud Najafi, Ali Zarrabi, Kwang Seok Ahn, Haroon Khan. Dual relationship between long non-coding RNAs and STAT3 signaling in different cancers: New insight to proliferation and metastasis. Life Sciences 2021; 270: 119006 doi: 10.1016/j.lfs.2020.119006
|
| 20 |
Elahe Seyed Hosseini, Ali Nikkhah, Amir Sotudeh, Marziyeh Alizadeh Zarei, Fatemeh Izadpanah, Hossein Nikzad, Hamed Haddad Kashani. The impact of LncRNA dysregulation on clinicopathology and survival of pancreatic cancer: a systematic review and meta-analysis (PRISMA compliant). Cancer Cell International 2021; 21(1) doi: 10.1186/s12935-021-02125-1
|
| 21 |
劲 黄. The Role and Research Status of LncRNAs in Pancreatic Cancer. Advances in Clinical Medicine 2023; 13(06): 10170 doi: 10.12677/ACM.2023.1361423
|
| 22 |
Baiping An, Yi Cai, Jie Zhu, Yuan Liu. Bioinformatics Analysis of LINC00917 Targets miR-3690/DDX39A Axis to Exacerbate Pancreatic Cancer Cell Growth Using Real-Time Quantitative Reverse Transcription PCR. Journal of Biomedical Nanotechnology 2024; 20(10): 1629 doi: 10.1166/jbn.2024.3499
|
| 23 |
Yiwei Li, Mohammed Najeeb Al Hallak, Philip A. Philip, Asfar S. Azmi, Ramzi M. Mohammad. Non-Coding RNAs in Pancreatic Cancer Diagnostics and Therapy: Focus on lncRNAs, circRNAs, and piRNAs. Cancers 2021; 13(16): 4161 doi: 10.3390/cancers13164161
|
| 24 |
Mingming Wu, Xiao Zhang, Xinghua Han, Vijay Pandey, Peter E. Lobie, Tao Zhu. The potential of long noncoding RNAs for precision medicine in human cancer. Cancer Letters 2021; 501: 12 doi: 10.1016/j.canlet.2020.11.040
|
| 25 |
Duo Li, Rui Wang, Na Wu, Yongqiang Yu. LncRNA HULC as a potential predictor of prognosis and clinicopathological features in patients with digestive system tumors: a meta-analysis. Aging 2022; 14(4): 1797 doi: 10.18632/aging.203903
|
| 26 |
Tohada M. Al-Noshokaty, Abdallah Mansour, Rehab Abdelhamid, Nourhan Abdellatif, Ayat Alaaeldien, Tasnim Reda, Nourhan M. Abdelmaksoud, Ahmed S. Doghish, Ahmed I. Abulsoud, Shereen Saeid Elshaer. Role of long non-coding RNAs in pancreatic cancer pathogenesis and treatment resistance- A review. Pathology - Research and Practice 2023; 245: 154438 doi: 10.1016/j.prp.2023.154438
|
| 27 |
Ankita Sharma, Shibasish Chowdhury, Sudeshna Mukherjee, Rajdeep Chowdhury. LncRNA HULC augments high glucose‐associated pancreatic cancer progression and drug resistance by enhancing YAP activity and autophagy. Biology of the Cell 2024; 116(9) doi: 10.1111/boc.202400034
|